These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2472467)

  • 21. Yellow fever monoclonal antibodies: type-specific and cross-reactive determinants identified by immunofluorescence.
    Monath TP; Schlesinger JJ; Brandriss MW; Cropp CB; Prange WC
    Am J Trop Med Hyg; 1984 Jul; 33(4):695-8. PubMed ID: 6206738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Examination of the envelope glycoprotein of yellow fever vaccine viruses with monoclonal antibodies.
    Barrett AD; Pryde A; Medlen AR; Ledger TN; Whitby JE; Gibson CA; DeSilva M; Groves DJ; Langley DJ; Minor PD
    Vaccine; 1989 Aug; 7(4):333-6. PubMed ID: 2479185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody responses against wild-type yellow fever virus and the 17D vaccine strain: characterization with human monoclonal antibody fragments and neutralization escape variants.
    Daffis S; Kontermann RE; Korimbocus J; Zeller H; Klenk HD; Ter Meulen J
    Virology; 2005 Jul; 337(2):262-72. PubMed ID: 15919103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of Live-Attenuated Yellow Fever 17D Vaccine Virus Is Localized to a High-Fidelity Replication Complex.
    Davis EH; Beck AS; Strother AE; Thompson JK; Widen SG; Higgs S; Wood TG; Barrett ADT
    mBio; 2019 Oct; 10(5):. PubMed ID: 31641088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Monoclonal antibodies to flavivirus antigens induced by a vaccinal strain of yellow fever].
    Gaĭdamovich SIa; Mel'nikova EE; Mikheeva TG; Shutkova TM; Sveshnikova NA
    Vopr Virusol; 1988; 33(4):461-5. PubMed ID: 2848367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunogenicity of a purified fragment of 17D yellow fever envelope protein.
    Brandriss MW; Schlesinger JJ; Walsh EE
    J Infect Dis; 1990 Jun; 161(6):1134-9. PubMed ID: 1693159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ontogeny of yellow fever 17D vaccine: RNA oligonucleotide fingerprint and monoclonal antibody analyses of vaccines produced world-wide.
    Monath TP; Kinney RM; Schlesinger JJ; Brandriss MW; Brès P
    J Gen Virol; 1983 Mar; 64 Pt 3():627-37. PubMed ID: 6298349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Variation in the biological function of envelope protein epitopes of yellow fever vaccine viruses detected with monoclonal antibodies.
    Ledger TN; Sil BK; Wills MR; Lewis G; Kinney RM; Jennings AD; Stephenson JR; Barrett AD
    Biologicals; 1992 Jun; 20(2):117-28. PubMed ID: 1389107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.
    Poland JD; Calisher CH; Monath TP; Downs WG; Murphy K
    Bull World Health Organ; 1981; 59(6):895-900. PubMed ID: 6978196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Isolation of plaque variants differing in virulence from the 17D strain of yellow fever virus.
    Liprandi F
    J Gen Virol; 1981 Oct; 56(Pt 2):363-70. PubMed ID: 7310380
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Viremia and immunogenicity in nonhuman primates of a tetravalent yellow fever-dengue chimeric vaccine: genetic reconstructions, dose adjustment, and antibody responses against wild-type dengue virus isolates.
    Guirakhoo F; Pugachev K; Arroyo J; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Draper K; Monath TP
    Virology; 2002 Jun; 298(1):146-59. PubMed ID: 12093182
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunoblotting reveals differences in the accumulation of envelope protein by wild-type and vaccine strains of yellow fever virus.
    Cane PA; Gould EA
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():557-64. PubMed ID: 2732701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monoclonal antibodies identify the NS5 yellow fever virus non-structural protein in the nuclei of infected cells.
    Buckley A; Gaidamovich S; Turchinskaya A; Gould EA
    J Gen Virol; 1992 May; 73 ( Pt 5)():1125-30. PubMed ID: 1534119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis.
    Guirakhoo F; Zhang ZX; Chambers TJ; Delagrave S; Arroyo J; Barrett AD; Monath TP
    Virology; 1999 May; 257(2):363-72. PubMed ID: 10329547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-Function of the Yellow Fever Virus Envelope Protein: Analysis of Antibody Epitopes.
    Davis EH; Barrett ADT
    Viral Immunol; 2020; 33(1):12-21. PubMed ID: 31682201
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of a yellow fever virus isolated from a fatal case of vaccine-associated human encephalitis.
    Jennings AD; Gibson CA; Miller BR; Mathews JH; Mitchell CJ; Roehrig JT; Wood DJ; Taffs F; Sil BK; Whitby SN
    J Infect Dis; 1994 Mar; 169(3):512-8. PubMed ID: 7908925
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genome Characterization of Yellow Fever Virus Wild-Type Strain Asibi, Parent to Live-Attenuated 17D Vaccine, from Three Different Sources.
    Davis EH; Thompson JK; Widen SG; Barrett ADT
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372589
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antigenic analysis of yellow fever virus glycoproteins: use of monoclonal antibodies in enzyme-linked immunosorbent assays.
    Cammack N; Gould EA
    J Virol Methods; 1986 May; 13(2):135-42. PubMed ID: 3016014
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Host-cell interaction of attenuated and wild-type strains of yellow fever virus can be differentiated at early stages of hepatocyte infection.
    Lefeuvre A; Contamin H; Decelle T; Fournier C; Lang J; Deubel V; Marianneau P
    Microbes Infect; 2006 May; 8(6):1530-8. PubMed ID: 16697681
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine.
    Wang E; Ryman KD; Jennings AD; Wood DJ; Taffs F; Minor PD; Sanders PG; Barrett AD
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2749-55. PubMed ID: 7595382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.